LDHA and cancer: In addition, morin (Figure 7E), EGCG (Figure 7F), the NADH competitive inhibitor GSK2837808A [255], pyruvate and NADH competitive inhibitors NHI1 and NHI2 [256], metamorphic inhibitor PSTMB [257], and piperidine derivative GNE140 [258] all have strong inhibitory and selective effects on LDHA and can inhibit cancer progression with less effect on normal cells, and are therefore considered as potential novel anticancer drugs [259].